HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qiong Chen Selected Research

cytofectin

10/2006[Experimental study of antisense oligodeoxynucleotide targeting survivin gene for cisplatin resistant human lung adeno-carcinoma xenograft in nude mice].
6/2006[Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qiong Chen Research Topics

Disease

42Neoplasms (Cancer)
08/2022 - 10/2005
14Adenocarcinoma of Lung
08/2022 - 10/2005
14Inflammation (Inflammations)
09/2021 - 01/2013
14Lung Neoplasms (Lung Cancer)
01/2021 - 10/2005
12Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 05/2015
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 09/2016
9Carcinogenesis
01/2022 - 01/2008
9Infections
12/2021 - 12/2010
8Neoplasm Metastasis (Metastasis)
04/2022 - 01/2012
8Hypoxia (Hypoxemia)
01/2022 - 01/2012
6Hemorrhage
12/2021 - 04/2008
6Glioblastoma (Glioblastoma Multiforme)
11/2016 - 11/2006
6Glioma (Gliomas)
11/2016 - 08/2006
5Stroke (Strokes)
01/2022 - 11/2015
5Fibrosis (Cirrhosis)
10/2021 - 01/2011
5Breast Neoplasms (Breast Cancer)
01/2021 - 01/2012
5Carcinoma (Carcinomatosis)
10/2015 - 10/2006
4Atrial Fibrillation
01/2022 - 01/2019
4Vascular Remodeling
01/2022 - 01/2015
4Cerebral Hemorrhage
01/2022 - 01/2020
4Endometriosis
07/2021 - 02/2013
4Hepatocellular Carcinoma (Hepatoma)
03/2021 - 02/2008
4Birth Weight (Birth Weights)
09/2018 - 09/2014
3Brain Injuries (Brain Injury)
01/2022 - 01/2019
3Lung Injury
09/2021 - 05/2015
3Emergence Delirium
04/2021 - 01/2020
3Aortic Dissection
04/2021 - 01/2020
3Reperfusion Injury
01/2019 - 07/2008
2Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2022 - 01/2020
2Neuroinflammatory Diseases
01/2022 - 04/2016
2Ischemic Stroke
01/2022 - 07/2020
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2022 - 12/2018
2Thrombosis (Thrombus)
12/2021 - 08/2021
2Epilepsy (Aura)
11/2021 - 01/2021
2Cerebral Infarction
11/2021 - 07/2020
2Dysbiosis
07/2021 - 11/2015
2Overweight
03/2021 - 01/2021
2Sepsis (Septicemia)
03/2021 - 05/2018
2Hypoglycemia (Reactive Hypoglycemia)
01/2021 - 01/2021
2Type 2 Diabetes Mellitus (MODY)
01/2021 - 02/2019
2Cross Infection (Nosocomial Infection)
01/2021 - 01/2015
2Atherosclerotic Plaque (Atheroma)
12/2020 - 11/2015
2COVID-19
07/2020 - 06/2020
2Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 01/2019
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 09/2017

Drug/Important Bio-Agent (IBA)

26Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2005
9Anti-Bacterial Agents (Antibiotics)IBA
11/2021 - 03/2008
8Messenger RNA (mRNA)IBA
01/2022 - 10/2006
8SmokeIBA
09/2021 - 05/2015
7Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2012
7Small Interfering RNA (siRNA)IBA
01/2021 - 10/2011
7Biological ProductsIBA
01/2021 - 10/2005
7Pharmaceutical PreparationsIBA
01/2020 - 02/2002
7Cisplatin (Platino)FDA LinkGeneric
01/2020 - 10/2005
6RNA (Ribonucleic Acid)IBA
01/2022 - 04/2008
5MicroRNAs (MicroRNA)IBA
01/2022 - 01/2015
5Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 01/2012
5ProgesteroneFDA LinkGeneric
10/2020 - 05/2013
5Long Noncoding RNAIBA
01/2020 - 08/2017
5Leucine (L-Leucine)FDA Link
11/2016 - 08/2006
4AntioxidantsIBA
07/2022 - 06/2011
4C-Reactive ProteinIBA
01/2022 - 05/2015
4Glucose (Dextrose)FDA LinkGeneric
01/2022 - 02/2019
4Tigecycline (Tygacil)FDA Link
12/2021 - 01/2014
4Gonadal Steroid Hormones (Sex Hormones)IBA
01/2021 - 05/2013
4Oxygen (Dioxygen)IBA
07/2020 - 07/2008
4Adrenal Cortex Hormones (Corticosteroids)IBA
06/2020 - 02/2015
4CytokinesIBA
01/2020 - 01/2008
4EnzymesIBA
04/2017 - 08/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2020
3InterleukinsIBA
07/2021 - 01/2017
3Therapeutic UsesIBA
01/2020 - 01/2013
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 10/2005
3CateninsIBA
01/2020 - 09/2017
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
12/2018 - 08/2006
3CollagenIBA
11/2017 - 01/2011
3Benzo(a)pyreneIBA
10/2017 - 01/2009
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2015 - 01/2008
3TeaIBA
01/2013 - 08/2008
3norcantharidinIBA
02/2012 - 01/2011
3Telomerase (Telomerase Reverse Transcriptase)IBA
10/2011 - 04/2008
3NF-kappa B (NF-kB)IBA
01/2008 - 08/2006
26-methyladenineIBA
08/2022 - 01/2021
2Interleukin-8 (Interleukin 8)IBA
01/2022 - 01/2018
2IronIBA
01/2022 - 01/2017
2Triggering Receptor Expressed on Myeloid Cells-1IBA
09/2021 - 07/2021
2LipopolysaccharidesIBA
09/2021 - 03/2018
2InflammasomesIBA
09/2021 - 07/2021
2ORALIT (ORS)IBA
03/2021 - 01/2016
2Phenobarbital (Luminal)FDA Link
01/2021 - 01/2017
2Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2020 - 01/2019

Therapy/Procedure

17Therapeutics
01/2022 - 10/2006
7Drug Therapy (Chemotherapy)
12/2022 - 10/2005
4Length of Stay
01/2022 - 06/2010
4Artificial Respiration (Mechanical Ventilation)
11/2021 - 07/2020
3Stents
01/2022 - 01/2020
3Catheter Ablation
01/2020 - 01/2019
2Immunotherapy
08/2022 - 01/2021
2Catheters
09/2021 - 08/2021
2Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2021 - 01/2020